CRPS earned the nickname ‘suicide disease’ after research found high rates of suicidal thinking among patients with this condition, driven by unrelenting pain rather than despair alone. The name describes a real risk, not a sentence. Support exists, and both the pain and the risk behind it can be addressed. (A 2014 study found nearly three in four CRPS patients screened at high risk for )
Living with a pain condition long enough, you eventually run into the name people use for CRPS in the corners of the internet where patients talk to each other: the suicide disease. It is not a name The Spero Clinic invented, and it is not one we use lightly. It exists because researchers went looking at how unrelenting nerve pain wears on the mind, and the numbers they found were serious enough to earn the condition its own grim nickname. If you found this page after hearing that name and wondering whether it applies to you, here is the honest version, the data behind it, and what actually changes it.
Where Did the Name ‘Suicide Disease’ Come From?
The nickname is not a marketing phrase or an exaggeration. Complex Regional Pain Syndrome (CRPS) produces some of the most severe, constant nerve pain documented in medicine, and clinicians who treat chronic pain populations have long noticed that patients with CRPS report suicidal thinking at rates well above other painful conditions. That pattern, not any single dramatic case, is what earned the name.
A 2014 clinical study of 39 patients diagnosed with CRPS Type 1 or Type 2, published in Psychiatry Investigation by Lee and colleagues, found that nearly three in four of them, 74.4 percent, screened at high risk for suicidal ideation. Ten of the 39 screened low risk. The same paper found that risk climbed with three specific factors: depression, how severe the pain was, and how much the condition had eroded a patient’s overall day-to-day functioning. None of the three factors are fixed in place. All three are addressed in treatment.
What Does the Research Actually Show?
CRPS did not invent this pattern on its own. The same researchers point to earlier work showing that people with chronic pain generally report lifetime suicidal ideation at rates of 5 to 14 percent, with attempt rates near 20 percent, and that depression shows up in 31 to 100 percent of chronic pain patients depending on the study. CRPS sits at the severe end of a spectrum that spans all serious chronic pain, which is part of why it carries the nickname while other painful conditions do not.
| Risk factor identified in the 2014 study | What it means in practice | What can change it |
|---|---|---|
| Depression (p=0.002) | The strongest single factor linked to suicidal ideation in the study population | Treated directly, alongside the pain, not after it |
| Pain severity (p=0.024) | Higher reported pain tracked with higher risk | Addressing what drives the nervous system’s pain signal, not only masking it |
| Low overall functioning score (p=0.027) | Loss of ability to work, socialize, or manage daily life independently | Rebuilding function step by step, even before pain is fully resolved |
CRPS itself is uncommon. Reporting from Pain News Network puts new diagnoses at roughly 26 per 100,000 people each year, part of why the condition still gets missed or mislabeled for years before a patient finds the right diagnosis. The question has also reached researchers studying adolescents, not only adults: a study titled ‘Suicidality in adolescents with Complex Regional Pain Syndrome (CRPS),’ published in European Psychiatry, confirms the risk pattern is not confined to grown patients living with the condition for decades.
Can a Name Like This Become a Self-Fulfilling Story?
Here is the part the nickname leaves out. None of the three risk factors the 2014 study identified are permanent features of having CRPS. Depression can be treated. Pain severity can be reduced. Functioning can be rebuilt, in small steps, long before pain is fully resolved. A percentage describes a study population. It does not describe you.
Progress with CRPS is rarely a straight line down and to the right. Pain that has been present for years does not resolve in a week because a person finally got a diagnosis or started a new program. It moves in advances and setbacks, often for months, and that unevenness is normal, not proof that nothing is working. What the research on suicidal ideation in CRPS actually says is that depression, pain severity, and reduced functioning drive the risk, not the diagnosis itself. Move any one of those three, and the picture changes. Addressable factors are not a life sentence. They are targets.
Pain specialists increasingly describe CRPS as involving dysregulation in the central and autonomic nervous system, the body’s threat-response and pain-signaling wiring staying switched on long after tissue has healed. That framing matters here, because it means the despair some patients describe is not a personal failing. It is a physiological response to a nervous system stuck in an alarm state, and physiological responses can shift with the right, sustained input over time.
What Goes Wrong When People Hear ‘Suicide Disease’?
Three mistakes show up often once someone learns the nickname.
- Treating the name as a diagnosis of despair, rather than a description of a documented risk pattern in a research population.
- Assuming a frightening statistic applies personally, without accounting for the specific factors, depression and unmanaged pain, that actually drive the risk.
- Staying quiet about suicidal thoughts because the subject feels shameful, when telling a provider is exactly what allows depression and pain severity, the two biggest levers in the research, to be treated directly instead of compounding in silence.
If you or someone you love with CRPS is having thoughts of ending their life, that is urgent, not embarrassing. Call or text 988 in the United States, any time, to reach the Suicide and Crisis Lifeline.
Common Questions About CRPS and Suicide Risk
Can CRPS cause depression? Yes. The same 2014 study that produced the 74.4 percent figure found depression was the strongest single factor linked to suicidal ideation in CRPS patients. Constant, severe pain wears down mood regulation over time. That is a physiological response to unrelenting pain, not a character weakness, and it is treatable alongside the pain itself.
How serious is CRPS? CRPS is considered one of the more severe chronic pain conditions in medicine, which is part of why it earned this nickname in the first place. Severity varies by person and by how early treatment starts. Serious is not the same as untreatable.
Does CRPS affect life expectancy? There is no reliable published data in this research showing that CRPS itself shortens life expectancy. The nickname reflects suicide risk tied to depression and unmanaged pain, which is a different question, and one that treatment can influence directly.
Is CRPS a real, physical condition? Yes. CRPS produces measurable, documented changes in how the nervous system processes pain signals. It is not something a patient is imagining, and it should never be treated as if it were.
If you are reading this because someone in your life has CRPS, or because you have it yourself and the nickname landed harder than you expected, the concrete next step is simple: name the pain and the mood together, out loud, to a provider who treats the nervous system driving both, not only the pain signal. That one conversation is what moves depression, pain severity, and functioning, the three factors the research actually points to, instead of leaving them to compound quietly. For the fuller picture of the condition itself, start with everything to know about CRPS. For what individualized progress can look like once treatment is underway, read what CRPS remission looks like, and if family strain is part of what you are carrying, CRPS is not your fault addresses that directly.
No outcome is guaranteed. What the data supports is this: the factors behind the nickname are the same factors treatment can change.
Source: Lee and colleagues, 2014, Psychiatry Investigation.
